Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

UDG Appoints Aerami Therapeutics CEO To Board; Cooke Becomes Chair

1st Oct 2020 09:09

(Alliance News) - UDG Healthcare PLC on Thursday said it has appointed Anne Whitaker as non-executive director with immediate effect.

Since October 2018, Whitaker serves as chief executive officer of Aerami Therapeutics, a clinical stage pharmaceutical and medical device company.

The healthcare advisory and communications services company also said Shane Cooke has now succeeded retiring Peter Gray as independent non-executive chair of the company. The chair change was announced back in August.

Shares in UDG were up 1.0% at 780.50 pence each in London on Thursday morning.

By Tapan Panchal; [email protected]

Copyright 2020 Alliance News Limited. All Rights Reserved.


Related Shares:

UDG.L
FTSE 100 Latest
Value8,809.74
Change53.53